Pfizer and BioNTech today said they plan to apply for Emergency Use Authorization (EUA) of a COVID-19 booster dose for healthy 5- to 11-year-olds based on results of a small study that has not been published or analyzed by independent experts.
The companies also plan to request authorization from the European Medicines Agency and other regulatory agencies around the world as soon as possible.
Pfizer said in a press release the third dose of its vaccine produced significant protection against the Omicron variant in children 5 to 11 in a small Phase 2/3 clinical trial.
link
This is a grotesque distortion of good science on top of earlier distortions. Many, many people are pretending not to know many things—all of them easily learned—to even consider doing this. ABN
American Buddhist Net 